DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)



company name or ticker
Company Photos
(Click to zoom)

Targacept Crumbles as Pfizer Pulls Out of Collaboration - Analyst Blog

3 Hale & Hearty Stocks for World Health Day - Analyst Blog

Why Some Pfizer, Inc. Investors Are Kicking Themselves Now

Zoetis is outperforming Pfizer. Could some investors be experiencing non-buyers' remorse?

Nektar Gets Movantik Milestone Payment from AstraZeneca - Analyst Blog

U.K. Portfolio Update: Q1 2015

Disruptive Innovation Changing the Fight Against Cancer

After decades of false starts, new immunotherapies are achieving long-lasting remissions in patients with extremely deadly cancers. Some doctors are even daring to use the word "cure."

Pharmacyclics Begins Imbruvica Combination Cancer Study - Analyst Blog

Drugs Claiming Weight Loss As A Side Effect Targeted By Consumer Groups - This Can Be Bullish For An

Drugs Claiming Weight Loss As A Side Effect Targeted By Consumer Groups - This Can Be Bullish For Anti-Obesity Drugs

Investor AB Has Money In Motion

3 Drugs Stocks Driving The Industry Higher

See More Articles...